Print Page   |   Contact Us   |   Your Cart   |   Sign In
Sign In
Sign In securely
Breaking News

6/22/2017 » 6/25/2017
2017 OSAP Annual Conference

News & Press: Daily Updates

New Intransally Administered, Needleless Dental Anesthetic Approved by the U.S. Food and Drug Admini

Tuesday, July 19, 2016   (0 Comments)

On June 29, 2016, the U.S. Food and Drug Administration approved Kovanazeā„¢ (St. Renatus, L.L.C.), a needleless, intranasally administered spray combination of the ester anesthetic tetracaine HCl plus the vasoconstrictor oxymetazoline HCl (6 mg/0.1 mg per 0.2 mL) for regional maxillary anesthesia.1


OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2017. Sponsorship does not imply endorsement by OSAP of a company's products or services.